Skip to main content
. 2017 Mar 14;114(13):E2786–E2795. doi: 10.1073/pnas.1616829114

Fig. S4.

Fig. S4.

Viability and cell permeability of infected BMDMs. (A and B) Viability at 18 hpi (A) and STYOX Green uptake over time (B) for Mlkl−/− BMDMs after specified treatment. (C and D) Viability in WT BMDMs at 18 hpi treated either (C) with increasing concentrations of the cIAP inhibitor, BV6, or (D) with necrostatin-1 (Nec-1). (E–G) Viability at 18 hpi (E) and STYOX Green uptake in (F) Myd88−/−and (G) Ticam1Lps2 (Trif−/−) BMDMs. Error bars indicate SD of the mean. **P < 0.01; ***P < 0.001. Horizontal dotted or dashed lines indicate 100% viability. Horizontal dashed line indicates 18 hpi when cell viability assays are conducted. Untr, untreated.